Outlook and Opportunities: Healthcare In the Era Of Personalized Medicine

30 September 2009 Past Event

Personalized medicine and cellular therapeutics could open new doors to safe and effective therapies. Research institutions, pharmaceutical companies and investors are looking to new avenues in which to advance the discovery of medicine tailored to fit the individual patient. On the renewed vitality of the stem cell are the hopes of millions of patients coping with diseases that may now become treatable. Dr. Ralph Garippa, Research Leader at Roche, Department of Discovery Technologies, will address the potential impact of cellular therapeutics on diagnostic medicine and personalized therapeutics within the pharmaceutical industry. He will address the impact these technologies may have both in the U.S. and abroad with respect to R&D and viable opportunities that may exist for life science companies and investors alike.

Insights

Act Now: Employer Obligations Under New York HERO Act
02 August 2021
Labor & Employment Law Perspectives
$15 Minimum Wage for Federal Government Contractors Starting in January 2022
02 August 2021
Labor & Employment Law Perspectives
Supreme Court Limits Patent Assignor Estoppel
02 August 2021
PharmaPatents
Review of Recent Whistleblower Developments
30 July 2021
Legal News: Whistleblower Developments
30th Annual Law of Product Distribution & Franchise Seminar
29 September | 7 & 20 October 2021
Milwaukee | Chicago | Dallas
7th National Telehealth Summit
4-5 October 2021
Miami Beach, FL
AHLA Fraud & Compliance Forum
21-22 September 2021
Baltimore, MD
2nd Clinical Trial Agreements Forum
16-17 September 2021
Online Livestream